GNTX posted a positive earnings reaction last Friday but heads into May with shorts pulling back and analysts nudging targets modestly higher — the most interesting tension is how little the Street moved despite what looked like a constructive print.
Q1 results on April 24 lifted the stock 3.6% on the day, and the week closed with a 0.6% gain. The stock trades at $22.90, still a meaningful discount to the consensus price target of around $29, implying roughly 27% upside on the Street's average estimate. That gap is notable, though it has been a persistent feature of the stock rather than a fresh catalyst.
Short interest has been gradually retreating since the earnings release, and the direction of travel is constructive. SI ran as high as 4.96% of the free float in the days before earnings, briefly spiked to 5.42% on April 8 during broader market volatility, and has since pulled back to 4.68%. The week-on-week decline is about 5.5%, extending a trend that started immediately post-print. Borrow costs remain negligible — at 0.49% annualised, there is no pressure on shorts from the financing side. Availability is wide open, with only around 2.9% of available shares currently on loan, well below the 52-week peak of 18.4%, which means the lending market is loose and new short positions face no squeeze dynamics.
Options positioning has ticked toward more caution but remains far from alarmed. The put/call ratio is running at 0.37, above its 20-day average of 0.26 — about 0.8 standard deviations elevated — but nowhere near the 52-week high of 1.28. The PCR briefly jumped to 0.75 on April 24, likely earnings-related hedging, and has since settled. Overall, options traders are slightly more defensive than they were a month ago but are not pricing in meaningful downside risk.
Analyst reaction to the earnings print was cautious optimism at modest scale. Baird raised its target from $25 to $26 while staying at Neutral. B. Riley lifted to $29, keeping its Buy. JPMorgan, which was already sceptical heading in, trimmed slightly to $27, also at Neutral. The broader direction across the coverage universe is a handful of mild upward revisions alongside persistent Neutral ratings from the larger houses — Goldman and JPMorgan both sit at Neutral with targets well above the current price but neither appears to be moving off the sideline. The consensus score on EPS momentum ranks in the 69th percentile on a 30-day basis, and EPS surprise lands in the 68th, suggesting the beat was real but not a dramatic outlier. The dividend score is high at 88th percentile; the last declared dividends in the data are $0.12 per quarter, though that data is dated and investors should verify the current payout directly.
Institutional ownership tells a steady story. Vanguard and BlackRock hold just over 10% and 9.6% respectively with minor additions last quarter. American Century added meaningfully, picking up over 3 million shares to reach 4.6% of the float. Dimensional also added roughly 1.3 million shares. The insider data is largely stale, with the most recent cluster of transactions dating to February — all sales, with the CEO included — but at modest values and low significance scores, consistent with routine compensation-related activity rather than a bearish signal.
The next scheduled earnings event is not yet confirmed in ORTEX, so the main thing to watch is whether the post-print short covering continues to build, and whether the persistent analyst price-target discount to current levels narrows as the auto parts sector digests broader tariff uncertainty — peers VC bounced hard on the week (+8.3%) while APTV and LEA both fell, leaving GNTX's modest outperformance looking selective rather than sector-wide.
See the live data behind this article on ORTEX.
Open GNTX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
